Physician profile
Gregory Ali
NPI 1871126813
$13,407.82
in general payments reported to CMS, 2019-2025
61 companies · $5,363 in 2025
The $5,363 reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,714 · 2022: $2,874 · 2023: $2,357 · 2024: $1,101 · 2025: $5,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,093 · Travel and Lodging: $402 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $270 · Education: $55.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,093.27 |
| Travel and Lodging | $401.60 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $269.78 |
| Education | $55.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,749.14 | 2021-2025 | Relistor |
| Nalu Medical, INC. | $1,232.67 | 2022-2023 | Nalu Neurostimulation System |
| Nevro Corp. | $1,088.95 | 2022-2024 | Senza |
| Teva Pharmaceuticals USA, INC. | $1,058.07 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Boston Scientific Corporation | $779.89 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $679.44 | 2021-2025 | Xtampza, Belbuca, Nucynta |
| Scilex Pharmaceuticals INC. | $564.76 | 2021-2024 | Ztlido |
| Emd Serono, INC. | $468.19 | 2025 | Mavenclad |
| Medtronic, INC. | $391.37 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Axsome Therapeutics, INC. | $386.81 | 2025 | Symbravo |
| Novartis Pharmaceuticals Corporation | $320.03 | 2022-2025 | |
| Tg Therapeutics, INC. | $306.38 | 2025 | |
| Amgen INC. | $296.08 | 2021-2025 | Uplizna |
| Alnylam Pharmaceuticals INC. | $276.75 | 2022-2025 | Amvuttra, Onpattro |
| Ucb, INC. | $268.58 | 2025 | Rystiggo, Fintepla, Nayzilam |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $219.48 | 2022-2025 | |
| Lundbeck LLC | $214.98 | 2025 | Vyepti, Rexulti |
| Pfizer INC. | $202.16 | 2021-2025 | |
| Lilly USA, LLC | $200.62 | 2025 | Kisunla |
| Neurelis, INC. | $198.69 | 2025 | Valtoco |
| Otsuka America Pharmaceutical, INC. | $176.98 | 2023-2025 | Nuedexta, Rexulti |
| Acadia Pharmaceuticals INC | $161.28 | 2025 | Nuplazid |
| Neurocrine Biosciences, INC. | $155.31 | 2025 | |
| Biogen, INC. | $125.29 | 2025 | Tysabri, Vumerity |
| Redhill Biopharma INC. | $119.58 | 2021-2023 | Aemcolo, Talicia, Movantik |
| Biohaven Pharmaceuticals, INC. | $115.35 | 2021 | |
| Vanda Pharmaceuticals INC. | $109.83 | 2025 | Ponvory |
| Astrazeneca Pharmaceuticals LP | $107.18 | 2025 | Wainua |
| Argenx US, INC. | $99.90 | 2025 | Vyvgart Hytrulo |
| Uswm, LLC | $96.38 | 2021 | |
| West Therapeutics Development, LLC | $95.87 | 2021 | |
| Genentech USA, INC. | $92.22 | 2025 | Ocrevus Zunovo, Ocrevus |
| Genzyme Corporation | $65.90 | 2025 | |
| Alexion Pharmaceuticals, INC. | $65.10 | 2025 | Ultomiris |
| Mallinckrodt Hospital Products INC. | $63.45 | 2025 | Acthar |
| Catalyst Pharmaceuticals, INC. | $62.26 | 2025 | |
| Merz Pharmaceuticals, LLC | $62.05 | 2025 | Inbrija, Xeomin, Ampyra |
| Livanova USA, INC. | $54.29 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Ani Pharmaceuticals, INC. | $52.66 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $52.33 | 2021-2023 | Supartz Fx Sodium Hyaluronate |
| Si-Bone, INC. | $51.35 | 2024-2025 | |
| Tersera Therapeutics LLC | $51.26 | 2024-2025 | Prialt |
| Celgene Corporation | $48.80 | 2025 | Zeposia |
| Averitas Pharma INC. | $44.27 | 2023 | Qutenza |
| Cycle Pharmaceuticals INC | $38.23 | 2025 | Tascenso Odt, Bafiertam, Ormalvi |
| Spr Therapeutics, INC | $35.94 | 2024-2025 | Sprint Pns System |
| Tanabe Pharma America, INC. | $31.81 | 2025 | Radicava |
| Protega Pharmaceutials INC | $26.66 | 2023 | Roxybond |
| Xeris Pharmaceuticals, INC. | $25.10 | 2025 | Keveyis |
| Grt US Holding, INC. | $24.64 | 2021 | |
| Aucta Pharmaceuticals, INC. | $22.69 | 2025 | Motpoly Xr |
| Vertex Pharmaceuticals Incorporated | $22.33 | 2025 | |
| Harmony Biosciences LLC | $22.04 | 2025 | |
| Siemens Medical Solutions USA, INC. | $21.40 | 2024 | Cios Select |
| Jazz Pharmaceuticals INC. | $17.20 | 2025 | |
| Hospira, INC. | $16.41 | 2025 | |
| Forte Bio-Pharma LLC | $15.76 | 2025 | Prolate, Nalocet, Tanlor |
| Almatica Pharma LLC | $15.11 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.89 | 2025 | Hyqvia |
| Amneal Pharmaceuticals LLC | $14.60 | 2025 | Brekiya |
| Relievant Medsystems, INC. | $11.08 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.